Viewing nowFendimen Tablets (Phendimetrazine Tartrate)
Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 200908479 · Approved 2009.12.07
Weight loss adjunct therapy for patients with obesity (high body mass index and risk factors)
This medication helps obese patients who do not respond to an appropriate diet and exercise regimen. It is used in patients with a body mass index (BMI) of 30 or more, or in those with BMI of 27 or more who have risk factors such as high blood pressure, diabetes, or hyperlipidemia. It is suitable for short-term adjunctive treatment of weight loss therapies based on calorie restriction and should be used alone, without combining with other appetite suppressants. This medication is effective in assisting healthy weight loss and in the treatment of obesity.
Phendimetrazine Tartrate is administered orally at a dose of 35 mg, 2 to 3 times a day, 1 hour before meals. The dosage should use the minimum effective dose and must be adjusted individually. For some patients, a dose of 17.5 mg once a day may be appropriate. Do not exceed a single dose of 70 mg taken 3 times a day. It is administered for a short period (within 4 weeks) and if satisfactory weight loss occurs within the first 4 weeks...
This medication should be used alone for a short period as using it with other appetite suppressants may cause serious heart disease. Combining this medication with other weight loss drugs is not recommended as safety and efficacy have not been established. Long-term use of this medication may significantly increase the risk of pulmonary hypertension, a fatal lung disease, so do not use it for more than 3 months. If symptoms such as shortness of breath, chest pain, fainting, or leg swelling occur, immediately stop taking the medication and visit a hospital. It is advisable not to use this medication in patients with heart disease such as valvular heart disease or those with heart murmurs, and to undergo cardiac examination before use. This medication should not be administered to individuals sensitive to adrenergic agents, those with cardiovascular disease, hyperthyroid patients, glaucoma patients, those who are mentally anxious or agitated, or those with a history of substance abuse. Additionally, it should not be taken by children under 16 years old, women who are pregnant or may become pregnant, or those with specific genetic lactose metabolism disorders. Patients with mild hypertension, diabetic patients, and nursing mothers should exercise caution when using this medication. This medication may cause side effects such as increased heart rate, increased blood pressure, anxiety, insomnia, dizziness, nausea, and constipation, so if symptoms are severe, consult a healthcare provider. Tolerance to the appetite-suppressing effect may develop within weeks, and if its effectiveness diminishes, do not increase the dose but stop taking the medication. This medication affects the central nervous system, so caution is advised when driving or operating dangerous machinery. Diabetic patients may need to adjust their insulin dosage while taking this medication. In case of overdose, serious symptoms such as anxiety, coma, seizures, abnormal blood pressure, and vomiting may occur, and immediate emergency treatment is needed. This medication should be stored out of the reach of children and is classified as a controlled substance, with risks of abuse and dependence, so it must be taken strictly according to a doctor's instructions. Suddenly stopping after prolonged high-dose treatment can lead to severe fatigue and depression, so it is safer to taper off gradually. It is crucial to avoid using this medication during pregnancy or if planning to become pregnant for the safety of the fetus. Nursing mothers should consult a doctor before taking this medication as it may be passed into breast milk.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.